The average one-year price target for Bionano Genomics (BMV:BNGO) has been revised to MX$89.76 / share. This is a decrease of 11.11% from the prior estimate of MX$100.98 dated October 1, 2026. These ...

Key TakeawaysTwist Bioscience shares fell 9% today with no company news, as Illumina dropped 5% in a broad selloff in tech and AI stocks. Twist’s run since mid-September came from AI deals and an ...

The average one-year price target for 10x Genomics (BMV:TXG) has been revised to MX$1,361.84 / share. This is an increase of 42.11% from the prior estimate of MX$958.28 dated October 1, 2026. These ...

BGI Genomics' COLOTECT® addresses colorectal cancer in LATAM through innovative non-invasive screening, enhancing early ...

ERS Genomics Limited ('ERS Genomics'), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with KU Leuven covering CRISPR/Cas9 activities at the Leuven ...

Soybean and other legume crops are central to global food and nutritional security, yet the genetic basis of many ...

Your genome could be hiding secrets about your health. Knowing them might be more trouble than it's worth ...

Mapmygenome has completed its acquisition of Vancouver-based dnaPower, expanding its North American operations and adding capabilities across DNA testing, microbiome health, longevity, ...

For rural Mainers with cancer, advanced care once meant driving to Boston or traveling to an academic center. A decade in, ...

View 10x Genomics Inc Class A TXG stock quote prices, financial information, real-time forecasts, and company news from CNN.

Genomics is revolutionizing cancer treatment by allowing personalized care that reduces the amount of chemotherapy and ...

A stock compressed to a 10-year low price to earnings (PE) ratio rarely reflects a permanently broken business. It usually ...